Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-25

Clinical Trial Update: Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the usefulness of medroxyprogesterone acetate in the follicular phase for oocyte donors undergoing ovarian stimulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Medroxyprogesterone acetate (Medroxyprogesterone acetate)

Snippet

Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA | Conditions: Infertility | Phase 3 | Status: COMPLETED